Ozon Pharmaceuticals ' IFRS net profit for the first 9 months of 2024 was ₽3.413 billion, an increase of 32.2% compared to ₽2.582 billion in the previous year. Revenue increased by 33.6% to ₽18.137 billion from ₽13.576 billion a year earlier.